Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low dose amiodarone reduces tumor growth and angiogenesis.
Steinberg E, Fluksman A, Zemmour C, Tischenko K, Karsch-Bluman A, Brill-Karniely Y, Birsner AE, D'Amato RJ, Benny O. Steinberg E, et al. Among authors: zemmour c. Sci Rep. 2020 Oct 22;10(1):18034. doi: 10.1038/s41598-020-75142-1. Sci Rep. 2020. PMID: 33093573 Free PMC article.
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French Center.
Ratone JP, Archimbaud C, Solovyev A, Zemmour C, Pesenti C, Hoibian S, Dahel Y, Marx M, De Chaisemartin C, Chanez B, Meillat H, Lelong B, Poizat F, Caillol F, Giovannini M. Ratone JP, et al. Among authors: zemmour c. J Gastrointestin Liver Dis. 2023 Sep 28;32(3):315-322. doi: 10.15403/jgld-4719. J Gastrointestin Liver Dis. 2023. PMID: 37774222 Free article.
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
Beaufils M, Amodru V, Tejeda M, Boher JM, Zemmour C, Chanez B, Chrétien AS, Gorvel L, Gravis G, Bruyat D, Mari R, Madroszyk A, Cuny T, Gonçalves A, Lisberg AE, Olive D, Tassy L, Castinetti F, Rochigneux P. Beaufils M, et al. Among authors: zemmour c. J Immunother Cancer. 2023 Aug;11(8):e006786. doi: 10.1136/jitc-2023-006786. J Immunother Cancer. 2023. PMID: 37536938 Free PMC article.
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.
Noel R, Zemmour C, Montes de Oca C, Belmecheri N, Aurran-Schleinitz T, Coso D, Lopez Almeida L, Mescam L, Vey N, Bladé JS, Slama B, Bouabdallah R, Schiano de Colella JM. Noel R, et al. Among authors: zemmour c. Hematology. 2023 Dec;28(1):2207948. doi: 10.1080/16078454.2023.2207948. Hematology. 2023. PMID: 37133334 Clinical Trial.
56 results